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Bacterial speciation is a fundamental evolutionary process characterized by diverging 43 
genotypic and phenotypic properties. However, the selective forces impacting genetic 44 
adaptations and how they relate to the biological changes underpinning the formation of a 45 
new bacterial species remain poorly understood. Here we show that the spore-forming, 46 
healthcare-associated enteropathogen Clostridium difficile is actively undergoing speciation. 47 
Applying large-scale genomic analysis of 906 strains, we demonstrate that the ongoing 48 
speciation process is linked to positive selection on core genes in the newly forming species 49 
that are involved in sporulation and the metabolism of simple dietary sugars. Functional 50 
validation demonstrates the new C. difficile produce more resistant spores and show 51 
increased sporulation and host colonization capacity when glucose or fructose is available for 52 
metabolism. Thus, we report the formation of an emerging C. difficile species, selected for 53 
metabolizing simple dietary sugars and producing high levels of resistant spores that is 54 
adapted for healthcare-mediated transmission. 55 
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The formation of a new bacterial species from its ancestor is characterized by genetic 67 
diversification and biological adaptation1-4. For decades, a polyphasic examination5, relying 68 
on genotypic and phenotypic properties of a bacterium, has been used to define and 69 
discriminate a “species”. The bacterial taxonomic classification framework has more recently 70 
used large-scale genome analysis to incorporate aspects of a bacterium’s natural history, such 71 
as ecology6, horizontal gene transfer1, recombination2 and phylogeny3. Although a more 72 
accurate definition of a bacterial species can be achieved with whole-genome-based 73 
approaches, we still lack a fundamental understanding of how selective forces impact 74 
adaptation of biological pathways and phenotypic changes leading to bacterial speciation. In 75 
this work, we describe the genome evolution and biological changes during the ongoing 76 
formation of a new C. difficile species that is highly specialized for human transmission in the 77 
modern healthcare system. 78 
C. difficile is a strictly anaerobic, Gram-positive bacterial species that produces highly 79 
resistant, metabolically dormant spores capable of rapid transmission between mammalian 80 
hosts through environmental reservoirs7. Over the past four decades, C. difficile has emerged 81 
as the leading cause of antibiotic-associated diarrhea worldwide, with a large burden on the 82 
healthcare system7,8. To define the evolutionary history and genetic changes underpinning the 83 
emergence of C. difficile as a healthcare pathogen, we performed whole-genome sequence 84 
analysis of 906 strains isolated from humans (n = 761), animals (n = 116) and environmental 85 
sources (n = 29) with representatives from 33 countries and the largest proportion originating 86 
from the UK (n = 465) (Supplementary Fig. 1; Supplementary Table 1; Supplementary Table 87 
2). This dataset is summarized visually here https://microreact.org/project/H1QidSp14. Our 88 
collection was designed to capture comprehensive C. difficile genetic diversity9 and includes 89 
13 high-quality and well-annotated reference genomes (Supplementary Table 2). Robust 90 
maximum likelihood phylogeny based on 1,322 concatenated single-copy core genes (Fig. 91 
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1a; Supplementary Table 3) illustrates the existence of four major phylogenetic groups within 92 
this collection. Bayesian analysis of population structure (BAPS) using concatenated 93 
alignment of 1,322 single-copy core genes corroborated the presence of the four distinct 94 
phylogenetic groupings (PGs 1-4) (Fig. 1a) that each harbor strains from different 95 
geographical locations, hosts and environmental sources which indicates signals of sympatric 96 
speciation. Each phylogenetic group also harbors distinct clinically relevant ribotypes (RT): 97 
PG1 (RT001, 002, 014); PG2 (RT027 and 244); PG3 (RT023 and 017); PG4 (RT078, 045 98 
and 033).  99 
The phylogeny was rooted using closely related species (C. bartlettii, C. hiranonis, C. 100 
ghonii and C. sordellii) as outgroups (Fig. 1a). This analysis indicated that three phylogenetic 101 
groups (PG1, 2 and 3) of C. difficile descended from the most diverse phylogenetic group 102 
(PG4). This was also supported by the frequency of single-nucleotide polymorphism (SNP) 103 
differences in pairwise comparisons between strains of PG4 and each of the other PGs versus 104 
the level of pairwise SNP differences between comparisons of PGs 1, 2 and 3 to each other 105 
(Supplementary Fig. 2). Interestingly, bacteria from PG4 display distinct colony 106 
morphologies compared to bacteria from PG 1, 2 and 3 when grown on nutrient agar plates 107 
(Supplementary Fig. 3), suggesting a link between C. difficile colony phenotype and 108 
genotype that distinguishes PG 1, 2 and 3 from PG4. 109 
Our previous genomic study using 30 C. difficile genomes indicated an ancient, 110 
genetically diverse species that likely emerged 1 to 85 million years ago10. Testing this 111 
estimate using our larger dataset indicated the species emerged approximately 13.5 million 112 
years (12.7-14.3 million) ago. Using the same BEAST11 analysis on our substantially 113 
expanded collection, we estimate the most recent common ancestor (MRCA) of PG4 (using 114 
RT078 lineage) arose approximately 385,000 (297,137-582,886) years ago. In contrast, the 115 
MRCA of the PG1, 2 and 3 groups (using RT027 lineage) arose approximately 76,000 116 
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(40,220-214,555) years ago. Bayesian skyline analysis reveals a population expansion of 117 
PG1, 2 and 3 groups (using RT027 lineage) around 1595 A.D., which occurred shortly before 118 
the emergence of the modern healthcare system in the 18th century (Supplementary Fig. 4). 119 
Combined, these observations suggest that PG4 emerged prior to the other PGs and that the 120 
PG1, 2 and 3 population structure started to expand just prior to the implementation of the 121 
modern healthcare system12. We therefore refer to PG1, 2 and 3 groups as C. difficile “clade 122 
A” and PG4 as C. difficile “clade B”. 123 
 To investigate genomic relatedness, we next performed pairwise Average Nucleotide 124 
Identity (ANI) analysis (Fig. 1b). This analysis revealed high nucleotide identity (ANI > 125 
95%) between PGs 1, 2 and 3 indicating that bacteria from these groups belong to the same 126 
species; however, ANI between PG4 and any other PG was either less than the species 127 
threshold (ANI > 95%) or on the borderline of the species threshold (94.04%-96.25%) (Fig. 128 
1b). To detect recombination events, FastGEAR analysis13 was performed on whole-genome 129 
sequences of 906 strains. While analysis identified increased recombination within C. difficile 130 
clade A (PG1-PG2: 1-102, PG1-PG3: 1-214, PG2-PG3: 1-96) (Supplementary Fig. 5) a 131 
restricted number of recombination events between C. difficile clade A and clade B was 132 
observed (PG1-PG4: 1-20, PG2-PG4: 1-25, PG3-PG4: 1-46). This analysis strongly indicates 133 
the presence of recombination barriers in the core genome that further distinguishes the two 134 
C. difficile clades and could encourage sympatric speciation. Furthermore, accessory genome 135 
functional analysis also shows a clear separation between clade A and clade B 136 
(Supplementary Fig. 6; Supplementary Table 4-5). We also observe a higher number of 137 
pseudogenes in clade A compared to clade B (Supplementary Fig. 7; Supplementary Table 6-138 
11). Taken together, these results indicate different selection pressures on the genomes of C. 139 
difficile clades A and B. 140 
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In addition to reduced rates of recombination events, advantageous genetic variants in 141 
a population driven by positive selective pressures, termed positive selection, are also a 142 
marker of speciation6. We determined the Ka/Ks ratios and identified 172 core genes in clade 143 
A and 93 core genes in clade B that were positively selected (Ka/Ks >1) (Fig. 2a; 144 
Supplementary Table 12-13). Functional annotation and enrichment analysis identified 145 
positively selected genes involved in carbohydrate and amino acid metabolism, sugar 146 
phosphotransferase system (PTS) and spore coat architecture and spore assembly in clade A 147 
(Fig. 2b). In contrast, the sulphur relay system was the only enriched functional category in 148 
positively selected genes from clade B. Notably, 26% (45 in total) of the positively selected 149 
genes in C. difficile clade A produce proteins that are either directly involved in spore 150 
production, are present in the mature spore proteome14 or are regulated by Spo0A15 or its 151 
sporulation-specific sigma factors16 (Fig. 2c). In contrast, no positively selected genes are 152 
directly involved in spore production in C. difficile clade B; however, 22.5% (21 genes in 153 
total) are either present in the mature spore proteome or are regulated by Spo0A or its 154 
sporulation specific sigma factors (Supplementary Fig. 8). The lack of overlap between 155 
sporulation-associated positively selected genes in the two lineages suggests a divergence of 156 
spore-mediated transmission functions. In addition, these results suggest functions important 157 
for host-to-host transmission have evolved in C. difficile clade A. 158 
We found 20 positively selected genes (Supplementary Table 12) in clade A whose 159 
products are components of the mature spore14,15 and could contribute to environmental 160 
survival17. As an example, sodA (superoxide dismutase A), a gene associated with spore coat 161 
assembly, has three-point mutations which are present in all clade A genomes but absent in 162 
clade B genomes (Supplementary Fig. 9). Spores derived from diverse C. difficile clades have 163 
a wide variation in resistance to microbiocidal free radicals from gas plasma18. To investigate 164 
if the phenotypic resistance properties of spores from the new lineage have evolved, we 165 
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exposed spores from both clades to hydrogen peroxide, a commonly used healthcare 166 
environmental disinfectant17. Spores derived from clade A were more resistant to 3% (P = 167 
0.0317) and 10% hydrogen peroxide (P = 0.0317) when compared to spores from clade B, 168 
although there was no difference in survival at 30% peroxide likely due to the overpowering 169 
bactericidal effect at this concentration (P = 0.1667) (Fig. 3a). 170 
 The master regulator of C. difficile sporulation, Spo0A, is under positive selection in 171 
C. difficile clade A only. Spo0A also controls other host colonization factors, such as flagella, 172 
and carbohydrate metabolism, potentially serving to mediate cellular processes to direct 173 
energy to spore production and host colonization to facilitate host-to-host transmission15. 174 
Interestingly, the clade A genomes contain genes under positive selection that are involved in 175 
fructose metabolism (fruABC and fruK), glycolysis (pgk and pyk), sorbitol (CD630_24170) 176 
and ribulose metabolism (rep1), and conversion of pyruvate to lactate (ldh). To further 177 
explore the link between sporulation and carbohydrate metabolism in clade A, we analyzed 178 
positively selected genes using KEGG pathways19 and manual curation. Manual curation of 179 
key enriched pathways across the 172 positively selected core genes in C. difficile clade A 180 
identified a complete fructose-specific PTS pathway and identified four genes (30%, 4/13) 181 
involved in anaerobic glycolysis during glucose metabolism (Supplementary Fig. 10). Other 182 
genes associated with enriched PTS pathways include genes used for the cellular uptake and 183 
metabolism of mannitol, cellobiose, glucitol/sorbitol, galactitol, mannose and ascorbate. 184 
Furthermore, comparative analysis of carbohydrate active enzymes (CAZymes)20 identified a 185 
clear separation of CAZymes between C. difficile clade A and clade B (Supplementary Fig. 186 
11; Supplementary Table 14). Combined, these observations suggest a divergence of 187 
functions between two C. difficile clades linked to metabolism of a broad range of simple 188 
dietary sugars 21. 189 
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The simple sugars glucose and fructose are increasingly used in diets within Western 190 
societies21. Interestingly, trehalose, a disaccharide of glucose, used as a food additive has 191 
impacted the emergence of some human virulent C. difficile variants22. Based on our genomic 192 
analysis, we hypothesized that dietary glucose or fructose could differentially impact host 193 
colonization by spores from C. difficile clade A or clade B. We therefore supplemented the 194 
drinking water of mice with either glucose, fructose or ribose and challenged with clade A or 195 
clade B strains. Ribose metabolic genes were not under positive selection so this sugar was 196 
included as a control. Mice challenged with clade A spores exhibited increased bacterial load 197 
when exposed to dietary glucose (P = 0.048) or fructose (P = 0.0045) compared to clade B 198 
(Fig. 3b). No difference in bacterial load was observed between C. difficile clade A and clade 199 
B without supplemented sugars or when supplemented with ribose (P = 0.2709) (Fig. 3b). 200 
The infectivity and transmission of C. difficile within healthcare settings is facilitated 201 
by environmental spore density23,24. To determine the impact of simple sugar availability on 202 
spore production rates we assessed the ability of the two lineages to form spores in basal 203 
defined medium (BDM) alone or supplemented with either glucose, fructose or ribose. While 204 
no difference was observed on the ribose control (P = 0.3095), C. difficile clade A strains 205 
exhibited increased spore production on glucose (P = 0.0317) or fructose (P = 0.0317) (Fig. 206 
3c). These results provide experimental validation and, together with our genomic 207 
predictions, suggest that enhanced host colonization and onward spore-mediated transmission 208 
with the consumption of simple dietary sugars is a feature of C. difficile clade A but not clade 209 
B. 210 
The rapid recent emergence of C. difficile as a significant healthcare pathogen has 211 
mainly been attributed to the genomic acquisition of antibiotic resistance and carbohydrate 212 
metabolic functions on mobile elements via horizontal gene transfer22,25. Here we show that 213 
these recent genomic adaptations have occurred in established, distinct evolutionary lineages 214 
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each with core genomes expressing unique, pre-existing transmission properties. We reveal 215 
the ongoing formation of a new species with biological and phenotypic properties consistent 216 
with a transmission cycle that was primed for human transmission in the modern healthcare 217 
system (Fig. 3d). Indeed, different transmission dynamics and host epidemiology have also 218 
been reported for C. difficile clade A (027 lineage26 and 017 lineage27) endemic in healthcare 219 
systems in different parts of the world, and the 078 lineage that likely enters the human 220 
population from livestock28-30. Further, broad epidemiological screens of C. difficile present 221 
in the healthcare system often highlight high abundances of C. difficile clade A as they 222 
represent 68.5% (USA), 74% (Europe) and 100% (Mainland China) of the infecting 223 
strains7,8,31,32. Thus, we report a link between C. difficile clade A speciation, adapted 224 
biological pathways and epidemiological patterns. In summary, our study elucidates how 225 
bacterial speciation may prime lineages to emerge and transmit in a process accelerated by 226 
modern human diet, the acquisition of antibiotic resistance or healthcare regimes. 227 
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Figure legends: 411 
Figure 1. Phylogeny and population structure of Clostridium difficile. (a) Maximum 412 
likelihood tree of 906 C. difficile strains constructed from the core genome alignment, 413 
excluding recombination events. Collapsed clades as triangles represent four Phylogenetic 414 
groups (PG1-4) identified by Bayesian analysis of population structure (BAPS). Number in 415 
parentheses indicates number of strains. Key PCR ribotypes in each PG are shown. Bootstrap 416 
values of key branches are shown next to the branches. Dates indicate estimated emergence 417 
of C. difficile species-13.5 million (range 12.7-14.3) years ago, PG4- 385,000 (range 418 
297,137-582,886) years ago and PG1-3- 76,000 (range 40,220-214,555) years ago. C. 419 
bartlettii, C. hiranonis, C. ghonii and C. sordellii were used as outgroups to root the tree. 420 
Scale bar indicates number of substitutions per site. (b) Distribution pattern of average 421 
nucleotide identity (ANI) for 906 C. difficile strains. Pairwise ANI calculations between 422 
different PGs are shown. Dotted red line indicates bacterial species cut-off. 423 
 424 
Figure 2. Adaptation of sporulation and metabolic genes in Clostridium difficile clade A. 425 
Positive selection analysis of C. difficile clade A and B based on 1,322 core genes. (a) 426 
Distribution of Ka/Ks ratio for the positively selected genes in C. difficile clade A (n = 172 427 
genes) and clade B (n = 93 genes) is shown. Error bars are standard error of the mean (SEM). 428 
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(b) Enriched functions in the positively selected genes of C. difficile clade A (n = 172 genes) 429 
and clade B (n = 93 genes) are shown. Y–axis represents number of positive selected genes in 430 
each enriched function. All are statistically significant (sugar phosphotransferase system (q = 431 
0.00167), fructose and mannose metabolism (q = 0.001173), sporulation, differentiation and 432 
germination (q = 0.0165), cysteine and methionine metabolism (q = 0.00279), sulphur relay 433 
system (q = 0.00791)). One-sided Fisher’s exact test with P value adjusted by Hochberg 434 
method. (c) Positively selected sporulation-associated genes in C. difficile clade A are shown 435 
in blue. Of the 172 genes under positive selection, 26% (45 in total) are either involved in 436 
spore production (sporulation stages I, III, IV and V), their proteins are present in the mature 437 
spore proteome or they are regulated by Spo0A or its sporulation specific sigma factors. 438 
 439 
Figure 3. Bacterial speciation is linked to increased host adaptation and transmission 440 
ability. (a) Spores of C. difficile clade A are more resistant to widely used hydrogen peroxide 441 
disinfectant. Spores of C. difficile clade A and clade B (n = 5 different ribotypes for both 442 
lineages) were exposed to hydrogen peroxide for 5 minutes, washed and plated. Recovered 443 
CFUs representing surviving germinated spores were counted and presented as a percentage 444 
of spores exposed to PBS. Mean and range of 3 independent experiments is presented, Mann-445 
Whitney unpaired two-tailed test. (b) Intestinal colonization of clade A strains is increased in 446 
the presence of simple sugars compared to clade B strains. Comparison of vegetative cell 447 
loads between C. difficile clade A (n = 1, RT027) and clade B (n = 1, RT078) strains in mice 448 
whose diet was supplemented with different sugars before challenging with spores. CFUs 449 
from fecal samples cultured 16 hours after C. difficile challenge are presented. Mean values 450 
of 5 mice are presented from 1 representative experiment which was repeated once with 451 
similar results, standard error of the mean (SEM), unpaired two-tailed t test. (c) Clade A 452 
strains produce more spores in the presence of simple sugars. C. difficile clade A and clade B 453 
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(n = 5 different ribotypes for both lineages) strains were grown on basal defined media in the 454 
presence or absence of different sugars, vegetative cells were killed by ethanol exposure and 455 
the number of CFUs representing germinated spores were counted. The percentage of spores 456 
recovered in the presence of sugars compared to BDM alone is presented. Mean and range of 457 
3 independent experiments is presented, Mann-Whitney unpaired two-tailed test. (d) 458 
Overview of adaptations in key aspects of the C. difficile clade A transmission cycle in 459 
human population. 460 
 461 
Online Methods 462 
Collection of C. difficile strains 463 
Laboratories worldwide were asked to send a diverse representation of their C. 464 
difficile collections to the Wellcome Sanger Institute (WSI). After receiving all shipped 465 
samples the DNA extraction was performed batch-wise using the same protocol and reagents 466 
to minimize bias. Phenol-Chloroform was the preferred method for extraction since it 467 
provides high DNA yield and intact chromosomal DNA.  468 
The genomes of 382 strains designated as C. difficile, by PCR ribotyping were sequenced and 469 
combined with our previous collection of 506 C. difficile strains, 13 high quality C. difficile 470 
reference strains and 5 publicly available C. difficile RT 244 strains making a total of 906 471 
strains analyzed in this study. This genome collection includes strains from humans (n = 472 
761), animals (n =116) and the environment (n = 29) that were collected from diverse 473 
geographic locations (UK; n = 465, Europe; n = 230, N-America; n = 111, Australia; n = 62, 474 
Asia; n = 38). Details of all strains are listed in Supplementary Table 1 and Supplementary 475 
Table 2, including the European Nucleotide Archive (ENA) sample accession numbers. 476 
Metadata of this C. difficile collection have been made freely publicly available through 477 
Microreact33 (https://microreact.org/project/H1QidSp14).  478 
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Bacterial culture and genomic DNA preparation 479 
C. difficile strains were cultured on blood agar plates for 48 hours, inoculated into 480 
brain–heart infusion broth supplemented with yeast extract and cysteine and grown overnight 481 
(16 hours) anaerobically at 37 °C. Cells were pelleted, washed with PBS, and genomic DNA 482 
preparation was performed using a phenol–chloroform extraction as previously described34. 483 
All culturing of C. difficile took place in anaerobic conditions (10% CO2, 10% H2, 80% N2) 484 
in a Whitley DG250 workstation at 37 °C. All reagents and media were reduced for 24 485 
hours in anaerobic conditions before use. 486 
DNA sequencing, assembly and annotation 487 
Paired-end multiplex libraries were prepared and sequenced using Illumina Hi-Seq 488 
platform with fragment size of 200-300 bp and a read length of 100 bp, as previously 489 
described35,36. An in-house pipeline developed at the WSI (https://github.com/sanger-490 
pathogens/Bio-AutomatedAnnotation) was used for bacterial assembly and annotation. It 491 
consisted of de novo assembly for each sequenced genome using Velvet v1.2.1037, SSPACE 492 
v2.038 and GapFiller v1.139 followed by annotation using Prokka v1.5-140. For the 13 high-493 
quality reference genomes, strains Liv024, TL178, TL176, TL174, CD305 and Liv022 were 494 
sequenced using 454 and Illumina sequencing platforms, BI-9 and M68 were sequenced 495 
using 454 and capillary sequencing technologies with the assembled data for these 8 strains 496 
been improved to an ‘Improved High Quality Draft’ genome standard41. Optical maps using 497 
the Argus Optical Mapping system were also generated for Liv024, TL178, TL176, TL174, 498 
CD305 and Liv022. The remaining strains are all contiguous and were all sequenced using 499 
454 and capillary sequencing technologies except for R20291 which also had Illumina data 500 
incorporated and 630 which was sequenced using capillary sequence data alone. 501 
Phylogenetic analysis, Pairwise SNP distances analysis and Average Nucleotide Identity 502 
analysis 503 
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The phylogenetic analysis was conducted by extracting nucleotide sequence of 1,322 504 
single copy core gene from each C. difficile genome using Roary42. The nucleotide sequences 505 
were concatenated and aligned with MAFFT v7.2043. Gubbins44 was used to mask 506 
recombination from concatenated alignment of these core genes and a maximum-likelihood 507 
tree was constructed using RAxML v8.2.845 with the best-fit model of nucleotide substitution 508 
(GTRGAMMA) calculated from ModelTest embedded in TOPALi v2.546 and 500 bootstrap 509 
replicates. The phylogeny was rooted using a distance-based tree generated using Mash 510 
v2.047, R package APE48 and genome assemblies of closely related species (C. bartlettii, C. 511 
hiranonis, C. ghonii and C. sordellii). All phylogenetic trees were visualized in iTOL49. 512 
Genomes of closely related C. difficile were downloaded from NCBI. Pairwise SNP distances 513 
analysis was performed on concatenated alignment of 1,322 single-copy core genes using 514 
SNP-Dist (https://github.com/tseemann/snp-dists). Average nucleotide analysis (ANI) was 515 
calculated by performing pairwise comparison of genome assemblies using MUMmer50. 516 
Population structure and recombination analysis 517 
Population structure based on concatenated alignment of 1,322 single-copy core genes 518 
of C. difficile was inferred using the HierBAPS51 with one clustering layers and 5, 10 and 20 519 
expected numbers of clusters (k) as input parameters. Recombination events across the 520 
whole-genome sequences were detected by mapping genomes against a reference genome 521 
(NCTC 13366; RT027) and using FastGear13 with default parameters. 522 
Functional genomic analysis  523 
To explore accessory genome and identify protein domains in a genome, we 524 
performed RPS-BLAST using COG database (accessed February 2019)52. All protein 525 
domains were classified in different functional categories using the COG database52 and were 526 
used to perform Discriminant Analysis of Principle Components (DAPC)53 implemented in 527 
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the R package Adegenet v2.0.154. Domain and functional enrichment analysis was calculated 528 
using one-sided Fisher’s exact test with P value adjusted by Hochberg method in R v3.2.2. 529 
Carbohydrate active enzymes (CAZymes) in a genome were identified using dbCAN 530 
v5.055 (HMM database of carbohydrate active enzyme annotation). Best hits include hits with 531 
E-value < 1 × 10-5 if alignment > 80 aa and hits with E-value < 1 × 10-3 if alignment < 80 aa, 532 
and alignment coverage > 0.3. Best hits were used to perform Discriminant Analysis of 533 
Principle Components (DAPC)53 implemented in the R package Adegenet v2.0.154.  534 
Functional annotation of positively selected genes was carried out using the Riley 535 
classification system56, KEGG Orthology57 and Pfam functional families58.  536 
Analysis of selective pressures.  537 
The aligned nucleotide sequences of each 1,322 single copy core genes were extracted 538 
from Roary's output. The ratio between the number of non-synonymous mutations (Ka) and 539 
the number of synonymous mutations (Ks) was calculated for the whole alignment and for 540 
the respective subsets of strains belonging to the PG1, 2, 3 as a group and PG4. The Ka/Ks 541 
ratio for each gene alignment was calculated with SeqinR v3.1. A Ka/Ks > 1 was considered 542 
as the threshold for identifying genes under positive selection.  543 
Pseudogenes analysis  544 
Nucleotide annotations of genes within a genome within each phylogenetic group 545 
were mapped against the protein sequences of the reference genome for its phylogenetic 546 
group (PG1: NCTC 13307(RT012), PG2: SRR2751302 (RT244), PG3: NCTC 14169 547 
(RT017), PG4: NCTC 14173 (RT078)) using TBLASTN as previously described59. 548 
Pseudogenes were called based on following criteria: genes with E value > 1 × 10-30 and 549 
sequence identity < 99% and which are absent in 90% members of a phylogenetics group. 550 
Genes in the reference genomes annotated as a pseudogene were also included in addition to 551 
genes in query genomes. 552 
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Analysis of estimating dates 553 
The aligned nucleotide sequences of each 222 core genes of C. difficile which are 554 
under neutral selection (Ka/Ks = 1) were extracted from Roary’s output. Gubbins44 was used 555 
to mask recombination from concatenated alignment of these core genes and used as an input 556 
for Bayesian Evolutionary Analysis Sampling Trees (BEAST) software package v2.4.111. In 557 
BEAST, the MCMC chain was run for 50 million generations, sampling every 1,000 states 558 
using the strict clock model (2.50 × 10−9 - 1.50 × 10−8 per site per year)10 and HKY four 559 
discrete gamma substitution model, each run in triplicate. Convergence of parameters were 560 
verified with Tracer v1.560 by inspecting the Effective Sample Sizes (ESS > 200). 561 
LogCombiner was used to remove 10% of the MCMC steps discarded as burn-ins and 562 
combine triplicates. The resulting file was used to infer the time of divergence from the most 563 
recent common ancestor for C. difficile, C. difficile clade A and clade B. The Bayesian 564 
skyline plot was generated with Tracer v1.560.  565 
C. difficile growth in vitro on selected carbon sources 566 
Basal defined medium (BDM)61 was used as the minimal medium to which selected 567 
carbon sources (2 g/l of glucose, fructose or ribose from Sigma-Aldrich) were added. C. 568 
difficile strains were grown on CCEY agar (Bioconnections) for two days; 125-ml 569 
Erlenmeyer flasks containing 10 ml of BDM with or without carbon sources were inoculated 570 
with C. difficile strains and incubated in anaerobic conditions at 37 ºC shaking at 180 rpm. 571 
After 48 hours, spores were enumerated by centrifuging the culture to a pellet, carefully 572 
decanting the BDM and re-suspending in 70% ethanol for 4 hours to kill vegetative cells. 573 
Following ethanol shock, spores were washed twice in PBS and plated in a serial dilution on 574 
YCFA media62 supplemented with 0.1% sodium taurocholate. Colony forming units 575 
(representing germinated spores) were counted 24 hours later. The experiment was performed 576 
independently 3 times for each strain. Clade A strains used were TL178 (RT002/ PG1), 577 
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TL174 (RT015/ PG1), R20291 (RT027/ PG2), CF5 (RT017/ PG3) and CD305 (RT023/ 578 
PG3). Clade B strains used were MON024 (RT033), CDM120 (RT078), WA12 (RT291), 579 
WA13 (RT228) and MON013 (RT127). Data were presented using GraphPad Prism v7.03. 580 
C. difficile spore resistance to disinfectant 581 
Spores were prepared by adapting the previous protocol18. In brief, C. difficile strains 582 
were streaked on CCEY media, the cells were harvested from the plates 48 hours later and 583 
subjecting to exposure in 70% ethanol for 4 hours to kill vegetative cells. The solution was 584 
then centrifuged, ethanol was decanted and the spores were washed once in 5 ml sterile saline 585 
(0.9% w/v) solution before being suspended in 5 ml of saline (0.9% w/v) with Tween20 586 
(0.05% v/v). 300 µl spore suspensions (at a concentration of approximately 106 spores) were 587 
exposed to 300 µl of 3%, 10% and 30% hydrogen peroxide (Fisher Scientific UK Limited) 588 
solutions for 5 minutes in addition to 300 µl PBS. The suspensions were then centrifuged, 589 
hydrogen peroxide or PBS was decanted and the spores were washed twice with PBS. 590 
Washed spores were plated on YCFA media with 0.1% sodium taurocholate to stimulate 591 
spore germination and colony forming units were counted 24 hours later. The experiment was 592 
performed independently 3 times for each strain. Clade A strains used were TL178 (RT002/ 593 
PG1), TL174 (RT015/ PG1), R20291 (RT027/ PG2), CF5 (RT017/ PG3) and CD305 594 
(RT023/ PG3). Clade B strains used were MON024 (RT033), CDM120 (RT078), WA12 595 
(RT291), WA13 (RT228) and MON013 (RT127). Data were presented using GraphPad 596 
Prism v7.03. 597 
In vivo C. difficile colonization experiment 598 
Five female 8-week-old C57BL/6 mice were given 250 mg/l clindamycin (Apollo 599 
Scientific) in drinking water. After 5 days, clindamycin treatment was interrupted and 100 600 
mM of glucose, fructose or ribose was added to mouse drinking water for the rest of the 601 
experiment; no sugars were given to control mice. After 3 days, mice were infected orally 602 
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with 6 × 103 spore/mouse of C. difficile R20291 (RT027) or M120 (RT078) strain. Fecal 603 
samples were collected from all mice before infection to check for pre-existing C. difficile 604 
contamination. Spore suspensions were prepared as described above18. After 16 hours, fecal 605 
samples were collected from all mice to determine viable C. difficile cell counts by serial 606 
dilution and plating on CCEY agar supplemented with 0.1% sodium taurocholate. The mean 607 
values of 5 mice are presented from 1 representative experiment which was repeated once 608 
with similar results. Data were presented using GraphPad Prism version 7.03. Ethical 609 
approval for mouse experiments was obtained from the Wellcome Sanger Institute.  610 
Reporting Summary 611 
Further information on research design is available in the Life Sciences Reporting 612 
Summary linked to this article. 613 
Data Availability 614 
Genomes have been deposited in the European Nucleotide Archive. Accession codes 615 
are listed in Supplementary Table 1. The 13 C. difficile reference isolates (Supplementary 616 
Table 2) are publicly available from the National Collection of Type Cultures (NCTC) and 617 
the annotation of these genomes are available from the Host-Microbiota Interactions Lab 618 
(HMIL; www.lawleylab.com), Wellcome Sanger Institute.  619 
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